Serving life sciences companies from offices in Greater China, Singapore, and Tokyo, we are strategically positioned to provide essential legal, business, regulatory, and governmental advice across the Asia-Pacific region. Our local knowledge and global reach allow us to help clients achieve their diverse and ambitious business objectives in the region’s dynamic life sciences arena.
Our lawyers understand the critical connection between the law, business, and science. We regularly help life sciences companies—as well as entities that invest in them—with inbound and outbound business in China, Japan, Korea, Australia, and Southeast Asia, including Singapore, Indonesia, Malaysia, the Philippines, Thailand, Vietnam, and Myanmar.
We work throughout the region to efficiently and strategically solve the myriad business, transactional, regulatory, intellectual property, litigation, and related issues our clients face throughout the product life cycle. Our command of local laws and regulations is particularly important to our advice on the US Foreign Corrupt Practices Act, antitrust and competition issues, and labor and employment matters.
Our multinational lawyers in Singapore, Beijing, Hong Kong, Shanghai, and Tokyo advise clients doing business in the full spectrum of life sciences industry sectors. Across the region, our team represents clients on matters related to capital markets; mergers and acquisitions; licensing and collaborations; private equity; finance and restructuring; intellectual property; white collar, government, and internal investigations; labor and employment; and international tax planning. In addition to global pharmaceutical, biotech, and medtech companies, we serve other entities involved in the sector, including investment banks; private equity, venture capital, and royalty monetization firms; precision medicine and digital health companies; contract research and contract manufacturing organizations; institutional lenders; independent director committees; and management groups.
